Form 4 holding
Chief Financial Officer
Cardiff Oncology, Inc.
- Security class
- Common Stock
- Shares / value
- 67,716
- Estimated value
- $338,580
- Report date
- 18 Dec 2024
- Price
- $5.00
- Ownership
- By Wife
James E. Levine - Chief Financial Officer at Cardiff Oncology, Inc.
Issuer-level insider activity
- Role
- Chief Financial Officer
- Issuer ticker
- CRDF on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by James E. Levine since 13 Sep 2025
Reported holdings for James E. Levine in Cardiff Oncology, Inc.
Form 4 holding
Chief Financial Officer
Cardiff Oncology, Inc.
- Security class
- Stock Options
- Shares / value
- 1,295,117
- Estimated value
- Report date
- 11 Mar 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for James E. Levine in Cardiff Oncology, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.